CorMedix, Inc. (CRMD)

Check out top investors' recommendation for CRMD
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
9.25
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Ram Selvaraju Aegis Capital Buy   Mar 26, '19     15.00  Mar 26, '20  N/A 
Ram Selvaraju Aegis Capital Buy   Feb 21, '19     3.50  Feb 21, '20  N/A 
Ram Selvaraju Aegis Capital Buy   Jan 18, '19     3.50  Jan 18, '20  N/A 
Ram Selvaraju Aegis Capital Buy   Aug 15, '18     3.00  Aug 15, '19  N/A 
Ram Selvaraju Aegis Capital Buy   May 23, '18     2.00  May 23, '19  N/A 
Ram Selvaraju Aegis Capital Buy   Apr 02, '18     4.00  Apr 02, '19  N/A 
Ram Selvaraju Aegis Capital Buy   Sep 25, '17     4.00  Sep 25, '18  N/A 
Ram Selvaraju Aegis Capital Buy   Aug 10, '17     3.00  Aug 10, '18  N/A 
Charles Graham Unaffiliated Buy   Mar 24, '16   2.38  2.52  Apr 24, '16  72.27% 
Ram Selvaraju Aegis Capital Buy   Dec 15, '15   2.08  6.50  Dec 15, '16  -24.52% 
Scott Henry Roth Capital Partners LLC Buy   Dec 24, '14   1.55    Dec 24, '15  33.55%